CYP2F1
protein-codingcytochrome P450 family 2 subfamily F member 1, the group of Cytochrome P450 family 2
Gene summary
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to dehydrogenate 3-methylindole, an endogenous toxin derived from the fermentation of tryptophan, as well as xenobiotic substrates such as naphthalene and ethoxycoumarin. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008]
- CYP2F
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~13.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CYP2F1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000774.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 1 | 1 | 4 | ||
| missense | 88 | 3 | 3 | 94 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 91 | 4 | 4 | 99 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000765.2 | 9 | MANE Select | |
| Ensembl | ENSP00000333534.2 | 9 | MANE Select | |
| Ensembl | ENSP00000443424.1 | 3 | Standard | |
| Ensembl | ENSP00000471416.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human)
- Oxidation by Cytochrome P450
- Tryptophan metabolism
- Metapathway biotransformation Phase I and II
- Phase I - Functionalization of compounds
Biological Process
- organic acid metabolic process
- xenobiotic metabolic process
- response to toxic substance
- naphthalene metabolic process
- trichloroethylene metabolic process
Molecular Function
- monooxygenase activity
- iron ion binding
- arachidonic acid epoxygenase activity
- steroid hydroxylase activity
- oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
Cellular Component
- cytoplasm
- endoplasmic reticulum membrane
- organelle membrane
- intracellular membrane-bounded organelle
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000331105
- Coding exons
- 9
- Length
- 13935
- Individuals with no LoFs
- 79498
- Homozygous LoFs
- 6001
- Heterozygous LoFs
- 40249
- Defined
- 125748
- p
- 0.205
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.00200 | 311 | 311 | 1.00 | 0.0000196 | 3188 |
| Missense (PolyPhen) | 95 | 100.87 | 0.94178 | 1029 | ||
| Synonymous | 0.785 | 124 | 136 | 0.914 | 0.00000893 | 1006 |
| Loss of Function | 0.771 | 15 | 18.6 | 0.807 | 9.39e-7 | 207 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.40 | 0.40 | notable |
| Latino/Admixed American | 0.14 | 0.14 | notable |
| Ashkenazi Jewish | 0.17 | 0.16 | notable |
| East Asian | 0.25 | 0.25 | notable |
| Finnish | 0.24 | 0.24 | notable |
| European (Non-Finnish) | 0.19 | 0.19 | notable |
| South Asian | 0.23 | 0.23 | notable |
| Other | 0.19 | 0.19 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May be involved in the metabolism of various pneumotoxicants including naphthalene. Is able to dealkylate ethoxycoumarin, propoxycoumarin, and pentoxyresorufin but possesses no activity toward ethoxyresorufin and only trace dearylation activity toward benzyloxyresorufin. Bioactivates 3- methylindole (3MI) by dehydrogenation to the putative electrophile 3-methylene-indolenine. {ECO:0000269|PubMed:1974816}.;
Intolerance Scores
- LoFtool
- 0.824
- RVIS EVS
- 1
- RVIS percentile EVS
- 90.77
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.317
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |